These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Mechanisms and consequences of hyperinflation. Demedts M Eur Respir J; 1990 Jun; 3(6):617-8. PubMed ID: 2379572 [No Abstract] [Full Text] [Related]
63. [The bronchial epithelium--more than a mechanical protection. The role of bronchial epithelial cells in defective healing has been determined]. Sköld M Lakartidningen; 1999 Oct; 96(41):4419-20, 4423-5. PubMed ID: 10553321 [TBL] [Abstract][Full Text] [Related]
64. Asthma in the elderly. Braman SS Clin Geriatr Med; 2003 Feb; 19(1):57-75. PubMed ID: 12735115 [TBL] [Abstract][Full Text] [Related]
66. [Changing understanding and definition of bronchial asthma]. Makino S Nihon Rinsho; 1996 Nov; 54(11):2881-5. PubMed ID: 8950924 [TBL] [Abstract][Full Text] [Related]
67. [Bronchial hyperreactivity]. Rodríguez de la Vega A Allergol Immunopathol (Madr); 1986; 14(5):363-7. PubMed ID: 3799404 [TBL] [Abstract][Full Text] [Related]
68. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm. Messina MS Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050 [TBL] [Abstract][Full Text] [Related]
69. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Postma DS; Kerstjens HA Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S187-92. PubMed ID: 9817744 [TBL] [Abstract][Full Text] [Related]
70. Drug therapy: Bronchodilator therapy (first of two parts). Webb-Johnson DC; Andrews JL N Engl J Med; 1977 Sep; 297(9):476-82. PubMed ID: 69991 [No Abstract] [Full Text] [Related]
72. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm]. Rozniecki J; Grabski W Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349 [No Abstract] [Full Text] [Related]
73. Pyrbuterol: a new bronchodilator. Phase I-single dose study. Steen SN; Ziment I; Thomas JS Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618 [No Abstract] [Full Text] [Related]
75. Localization and mechanisms of airway responses. Ingram RH; McFadden ER N Engl J Med; 1977 Sep; 297(11):596-600. PubMed ID: 887118 [No Abstract] [Full Text] [Related]
76. Control of airway caliber by autonomic nerves in asthma and in chronic obstructive pulmonary disease. de Jongste JC; Jongejan RC; Kerrebijn KF Am Rev Respir Dis; 1991 Jun; 143(6):1421-6. PubMed ID: 2048831 [TBL] [Abstract][Full Text] [Related]
77. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study. Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821 [TBL] [Abstract][Full Text] [Related]
78. [Asthma therapy with phentolamine]. Marcelle R Acta Allergol; 1969 Dec; 24(6):432-46. PubMed ID: 4392738 [No Abstract] [Full Text] [Related]
79. Nocturnal asthma and the use of theophylline. Martin RJ Clin Exp Allergy; 1998 Aug; 28 Suppl 3():64-70. PubMed ID: 9756189 [TBL] [Abstract][Full Text] [Related]
80. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. Busse WW J Allergy Clin Immunol; 1990 Apr; 85(4):671-83. PubMed ID: 2182693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]